Overview

Drug discovery aims to find and develop molecules that act on disease-relevant targets or biological processes, while balancing efficacy, safety, and the ability to make them. AI methods include graph and 3D models for predicting molecular properties, binding, and toxicity; generative models for proposing or editing molecules; and knowledge graphs and omics models for prioritizing targets and interpreting biological responses. Search and design methods increasingly combine these predictions with docking, synthesis constraints, experimental data, and tools coordinated by AI agents. A central challenge is that strong results on standard benchmarks may not transfer to unseen targets, chemistry, or assays, and computational scores still need reliable experimental validation.

Latest papers

CardsList

164 papers23 papers in the last four weeks, up 156% on the four weeks before. 0.1% of all new papers.

  1. Exploring Drug Safety Through Knowledge Graphs: Protein Kinase Inhibitors as a Case Study

    Feb 17, 2026David Jackson, Michael Gertz, Jürgen HesserClinical Risk PredictionBiomedical KGs

  2. Molecular Design beyond Training Data with Novel Extended Objective Functionals of Generative AI Models Driven by Quantum Annealing Computer

    Feb 17, 2026Hayato Kunugi, Mohsen Rahmani, Yosuke Iyama +8Molecular GenerationQuantum Generative Modeling

  3. AceFF: A State-of-the-Art Machine Learning Potential for Small Molecules

    Jan 2, 2026Stephen E. Farr, Stefan Doerr, Antonio Mirarchi +4Machine Learning Interatomic PotentialsDrug Discovery

  4. FRAGMENTA: Efficient End-to-end Fragmentation-based Generative Model with Agentic Tuning for Drug Lead Optimization in Small Data Regime

    Nov 25, 2025Yuto Suzuki, Paul Awolade, Daniel V. LaBarbera +1Molecular GenerationMolecular Optimization

  5. STAR-VAE: A Scalable Latent-Variable Transformer for Controllable Molecular Generation

    Nov 4, 2025Bum Chul Kwon, Ben Shapira, Moshiko Raboh +7Molecular OptimizationTransformer

  6. APEX: Approximate-but-exhaustive search for ultra-large combinatorial synthesis libraries

    Oct 28, 2025Aryan Pedawi, Jordi Silvestre-Ryan, Bradley Worley +5Surrogate-Assisted OptimizationAI-Assisted Scientific Research

  7. A Large Scale Investigation of Scaling Limits in Chemical Language Models

    Aug 19, 2025Roshan Balaji, Kamran Chitsaz, Quentin Fournier +2Chemical Language ModelsLanguage Model Scaling Laws

  8. DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search

    Jul 10, 2025Zerui Yang, Yuwei Wan, Siyu Yan +3Drug DiscoveryAgentic RAG

  9. Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Networks with Group Lasso Regularization

    Jul 4, 2025Zanyu Shi, Yang Wang, Pathum M. Weerawarna +4Protein-Ligand Binding Affinity PredictionMolecular Property Prediction

  10. OmegAMP: Targeted AMP Discovery via Biologically Informed Generation

    Apr 24, 2025Diogo Soares, Leon Hetzel, Paulina Szymczak +6Molecular GenerationConditional Generative Modeling

  11. Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

    Mar 4, 2025Yepeng Huang, Xiaorui Su, Varun Ullanat +10Clinical Outcome PredictionMultimodal Learning

  12. MARS: A neurosymbolic approach for interpretable drug discovery

    Oct 2, 2024Lauren Nicole DeLong, Yojana Gadiya, Paola Galdi +2Interpretable MLAI-Assisted Scientific Research

  13. DrugAgent: Reliable Multi-Agent Integration of Conflicting Biomedical Evidence for Drug-Target Interaction Assessment

    Aug 23, 2024Yoshitaka Inoue, Tianci Song, Xinling Wang +3Multi-Agent LLM SystemsLLM Agent Reliability

  14. Small Molecule Optimization with Large Language Models

    Jul 26, 2024Philipp Guevorguian, Menua Bedrosian, Tigran Fahradyan +3Molecular OptimizationEvolutionary Optimization